CIDP associated with LM1 antibodies
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
CIDP associated with LM1 antibodies. This may mark a subclass of CIDP. It is present in 10% of cases. Fully referenced neurology checklist.
Demographic features
- This may mark a subclass of CIDP
- It is present in 10% of cases
- It is more frequent in elderly subjects
Clinical features
Locked: subscribe to see this section.
Treatment
Locked: subscribe to see this section.
References
- Ogata H, Yamasaki R, Hiwatashi A, et al. Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy. Ann Clin Transl Neurol 2015; 2:960-971.
- Kuwahara M, Suzuki H, Samukawa M, Hamada Y, Takada K, Kusonoki S. Clinical features of CIDP with LM1-associated antibodies. JNNP 2013; 84:573-575.
